Evidence map›Paper›PMID 40063595›Full record

ArticleSchizophrenia bulletin2025

Cerebellar-Cortical Connectivity and Prediction of Antipsychotic Treatment Response in First-Episode Psychosis.

Halil Aziz Velioglu, Julie Moehringer, Todd Lencz, Juan A Gallego, John Cholewa, Yevgeniy Kats, Anita D Barber, Michael L Birnbaum, Delbert G Robinson, Hengyi Cao and 1 more

Abstract read
In one paragraph

Article in Schizophrenia bulletin, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Halil Aziz VeliogluInstitute of Behavioral Science, Feinstein Institutes for Medical Research, Manhasset, NY 11030, United States.ORCID 0000-0002-2306-5937
Julie MoehringerInstitute of Behavioral Science, Feinstein Institutes for Medical Research, Manhasset, NY 11030, United States.
Todd LenczInstitute of Behavioral Science, Feinstein Institutes for Medical Research, Manhasset, NY 11030, United States.ORCID 0000-0001-8586-338X
Juan A GallegoInstitute of Behavioral Science, Feinstein Institutes for Medical Research, Manhasset, NY 11030, United States.
John CholewaInstitute of Behavioral Science, Feinstein Institutes for Medical Research, Manhasset, NY 11030, United States.
Yevgeniy KatsInstitute of Behavioral Science, Feinstein Institutes for Medical Research, Manhasset, NY 11030, United States.
Anita D BarberInstitute of Behavioral Science, Feinstein Institutes for Medical Research, Manhasset, NY 11030, United States.
Michael L BirnbaumDepartment of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, NYC, NY 10032, United States.
Delbert G RobinsonInstitute of Behavioral Science, Feinstein Institutes for Medical Research, Manhasset, NY 11030, United States.ORCID 0000-0001-6606-4507
Hengyi CaoInstitute of Behavioral Science, Feinstein Institutes for Medical Research, Manhasset, NY 11030, United States.
Anil K MalhotraInstitute of Behavioral Science, Feinstein Institutes for Medical Research, Manhasset, NY 11030, United States.

Funding

Striatal D2/D3 Dopamine receptor availability in first episode schizophreniaP50MH080173 · NIMH · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI KANE, JOHN M · 2008 to 2012
$10.4M
PREVENTING MORBIDITY IN FIRST EPISODE SCHIZOPHRENIAR01MH060004 · NIMH · LONG ISLAND JEWISH MEDICAL CENTER · PI ROBINSON, DELBERT G · 1998 to 2008
$5.2M
Striatal Connectivity and Clinical Outcome in PsychosisR01MH108654 · NIMH · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI MALHOTRA, ANIL K · 2016 to 2021
$2.8M
Development of Cerebellar-Cortical Functional Connectivity in Youth and Its Prediction of PsychosisR01MH138682 · NIMH · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI Hengyi Cao · 2025 to 2026
$854k
Feinstein Institutes Barbara Zucker Emerging Scientist P50MH080173 and R01MH108654NIH HHS R01MH138682NIMH NIH HHS P50 MH080173NIMH NIH HHS R01 MH060004NIMH NIH HHS R01 MH108654NIMH NIH HHS R01 MH138682
6 · The paper itself

Abstract

backgroundThe cerebellum has traditionally been associated with motor functions, but recent evidence highlights its critical role in cognitive and emotional regulation, contributing to the neuropathology of schizophrenia. Our previous data-driven research demonstrated that cerebellar-cortical functional connectivity can predict antipsychotic treatment outcomes in first-episode psychosis (FEP). The present study aimed to investigate specific cerebellar functional systems involved in treatment prediction. STUDY

designThis study included 127 patients with FEP who underwent 12 weeks of antipsychotic monotherapy (either risperidone or aripiprazole). Baseline resting-state functional MRI data were collected from two 3T scanners, and functional connectivity between 10 predefined cerebellar functional systems and the whole brain was analyzed. Psychotic symptom changes were measured using the Brief Psychiatric Rating Scale-Anchored version (BPRS-A). Connectivity patterns were examined in relation to treatment outcomes. STUDY

resultsHigher baseline connectivity between the cerebellar auditory system and cortical regions, including the visual cortex, dorsolateral prefrontal cortex, and the hippocampus, predicted worse treatment outcome. In contrast, stronger connectivity between cerebellar cognitive systems (default mode and frontoparietal networks) and the anterior cingulate cortex (ACC) and medial prefrontal cortex was associated with better treatment outcome. These findings were consistently present in data acquired from both scanners and both drugs.

conclusionsOur results identify specific cerebellar-cortical circuitries as prognostic biomarkers for predicting psychosis treatment outcomes, and suggest that cerebellar auditory and cognitive systems may be potential targets for future interventions aimed at improving treatment efficacy in FEP.

Indexed as

Antipsychotic AgentsAripiprazoleCerebellumCerebral CortexConnectomeDefault Mode NetworkNerve NetOutcome Assessment, Health CarePsychotic DisordersRisperidoneSchizophreniaVisual CortexAdolescentAdultFemaleGyrus CinguliAntipsychotic AgentsAripiprazoleRisperidoneauditory systemcerebellar-cortical connectivitydefault mode networkfirst episode psychosisfrontoparietal networkprognostic biomarkers

Identifiers

PMID40063595
PMCPMC12597522

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.